Mefuparib hydrochloride

Mefuparib hydrochloride is the hydrochloride salt of mefuparib. It is a potent poly(ADP-ribose) polymerase inhibitor which exhibits strong anticancer activity and also inhibits SARS-CoV-2 in cell culture. Among its listed roles, it functions as a anticoronaviral agent, an antineoplastic agent, an EC 2.4.2.30 (NAD(+) ADP-ribosyltransferase) inhibitor and an apoptosis inducer. It includes a mefuparib(1+). It is grouped under the following drug class(es): PARP Inhibitors. The directory classifies it as a under development API with a synthetic source/manufacturing origin. Other names for this substance include 5-Fluoro-2-(4-((methylamino)methyl)phenyl)-7-benzofurancarboxamide hydrochloride 7-Benzofurancarboxamide, 5-fluoro-2-(4-((methylamino)methyl)phenyl)- and hydrochloride (1:1). Its PubChem CID is 117734810.

CAS No 1449746-00-2
Molecular Formula C17H16ClFN2O2
Molecular Weight 334.8 g/mol
Synonyms 5-fluoro-2-[4-(methylaminomethyl)phenyl]-1-benzofuran-7-carboxamide;hydrochloride

Frequently Asked Questions